![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1421-9913|49|2|120-124
ISSN: 0014-3022
Source: European Neurology, Vol.49, Iss.2, 2003-02, pp. : 120-124
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
European Neurology, Vol. 49, Iss. 2, 2003-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Other Neuroprotective Therapies on Trial in Acute Stroke
Cerebrovascular Diseases, Vol. 21, Iss. 2, 2006-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Multinational Randomised Controlled Trial of Lubeluzole in Acute Ischaemic Stroke
Cerebrovascular Diseases, Vol. 8, Iss. 3, 1998-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Outcome Analysis in Clinical Trial Design for Acute Stroke: Physicians’ Attitudes and Choices
Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. :